BioSpectrum Asia - September 2022Add to Favorites

BioSpectrum Asia - September 2022Add to Favorites

Få ubegrenset med Magzter GOLD

Les BioSpectrum Asia og 9,000+ andre magasiner og aviser med bare ett abonnement  Se katalog

1 Måned $9.99

1 År$99.99

$8/måned

(OR)

Abonner kun på BioSpectrum Asia

1 år $10.99

Spare 7%

Kjøp denne utgaven $0.99

Gave BioSpectrum Asia

7-Day No Questions Asked Refund7-Day No Questions
Asked Refund Policy

 ⓘ

Digital Subscription.Instant Access.

Digitalt abonnement
Umiddelbar tilgang

Verified Secure Payment

Verifisert sikker
Betaling

I denne utgaven

INCUBATORS IGNITING BIOSCIENCE ECOSYSTEM
Incubators and accelerators are driving small and medium enterprises (SMEs) in Asia
through the development of novel therapeutics and encouraging innovations and
commercialisation. Biotechnology incubators provide a stimulating environment that
attracts investors, talent, and companies to collaborate on research, thereby fostering
industry growth. While the appetite for laboratory space is constantly growing among
biotech ventures, countries in the Asia Pacific (APAC) region are actively investing
to construct life science hubs that foster innovation strategies and strengthen R&D
capabilities. Let’s explore prominent startup incubators and accelerators in key APAC
economies that are cultivating biotech innovations to create unicorns.

India approves Corbevax as first heterologous COVID-19 booster shot for 18+

ANOTHER IMMUNITY VACCINE

India approves Corbevax as first heterologous COVID-19 booster shot for 18+

1 min

Singapore grants interim authorisation for AstraZeneca's antiviral mAb Evusheld

ANTIBIOTIC

Singapore grants interim authorisation for AstraZeneca's antiviral mAb Evusheld

1 min

NZ evaluates Māori Influenza and Measles vaccination programme of 2021

The Ministry of Health in New Zealand, which oversees the Maori Influenza and Measles Vaccination Programme (MIMVP) has released a report on its findings for 2021, identifying which initiatives worked and what could be improved in future.

NZ evaluates Māori Influenza and Measles vaccination programme of 2021

1 min

Novavax’s COVID-19 vaccine receives approval for adolescents in Asian region

Novavax’s manufacturing partnership with Serum Institute of India

Novavax’s COVID-19 vaccine receives approval for adolescents in Asian region

1 min

AstraZeneca signs MoU to empower breast cancer community in Singapore

AstraZeneca Singapore has signed a Memorandum of Understanding (MoU) with Breast Cancer Foundation (BCF) to improve the overall breast cancer awareness, detection rates, and patients’ access to breast cancer treatment in Singapore.

AstraZeneca signs MoU to empower breast cancer community in Singapore

1 min

Wipro GE Healthcare & Boston Scientific to offer advanced heart care in India

Wipro GE Healthcare, a medical technology, diagnostics and digital solutions innovator, has announced its collaboration with Boston Scientific, a medical device manufacturer to provide end-to-end innovative interventional cardiac care solutions in India.

Wipro GE Healthcare & Boston Scientific to offer advanced heart care in India

1 min

Everest Medicines, Gilead announce $455M oncology deal for Asian rights

China-based Everest Medicines has entered into an agreement with Immunomedics, Inc., a wholly-owned subsidiary of California-based Gilead Sciences, Inc., whereby Immunomedics will obtain exclusive rights to develop and commercialise Trodelvy (sacituzumab govitecan) in Greater China, South Korea, Singapore, Indonesia, Philippines, Vietnam, Thailand, Malaysia and Mongolia.

Everest Medicines, Gilead announce $455M oncology deal for Asian rights

1 min

Carlyle to invest ¥7B, pick up minority stake in Japanese MedTech CureApp

Global investment firm Carlyle has announced a strategic partnership with CureApp, Inc., a leading Japanese medical technology startup and prescription digital therapeutics provider, through an acquisition of a significant minority stake in the company.

Carlyle to invest ¥7B, pick up minority stake in Japanese MedTech CureApp

1 min

Insilico Medicine raises $95M from Aramco’s Prosperity7 Ventures

Hong Kong-based startup Insilico Medicine, a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, has completed a second closing of its Series D round, led by Prosperity7 Ventures, the diversified growth fund of Aramco Ventures, bringing the total Series D financing to $95 million.

Insilico Medicine raises $95M from Aramco’s Prosperity7 Ventures

1 min

INCUBATORS IGNITING BIOSCIENCE ECOSYSTEM

Incubators and accelerators are driving small and medium enterprises (SMEs) in Asia through the development of novel therapeutics and encouraging innovations and commercialisation. Biotechnology incubators provide a stimulating environment that attracts investors, talent, and companies to collaborate on research, thereby fostering industry growth. While the appetite for laboratory space is constantly growing among biotech ventures, countries in the Asia Pacific (APAC) region are actively investing to construct life science hubs that foster innovation strategies and strengthen R&D capabilities. Let’s explore prominent startup incubators and accelerators in key APAC economies that are cultivating biotech innovations to create unicorns.

INCUBATORS IGNITING BIOSCIENCE ECOSYSTEM

10+ mins

Autoimmune Diseases - Taming The Enemy Within

Autoimmune diseases are one of the hot targets in the pharma industry. There has been a flurry of activities in this space in recent times. While immunosuppressants and steroids have typically been used to treat these diseases, targeted therapies are advancing. By aiming at specific genes or cells, researchers can boost effectiveness and reduce side effects associated with conventional treatments. Let’s look at some of the advances in the battle against autoimmune diseases:

Autoimmune Diseases - Taming The Enemy Within

5 mins

'Asia is constantly strengthening its digitisation and connectivity, making it an attractive market to invest in'

Eppendorf, a leading global company, catering instruments, consumables, solutions and services for life science institutes and businesses worldwide recently inaugurated its new subsidiary in Singapore’s Biopolis Science Centre.

'Asia is constantly strengthening its digitisation and connectivity, making it an attractive market to invest in'

6 mins

'Growing demand for low-cost remote patient monitoring services, CIS & EMRs will propel digital healthcare platform adoption'

On July 25, 2022, Healthcare Triangle, Inc (HCT), a healthcare information technology company focused on cloud innovative solutions, data science, and data analytics platforms for the healthcare and life sciences industry announced the launch of its Singapore unit with a focus to bolster digital healthcare in Singapore and across the Asia Pacific.

'Growing demand for low-cost remote patient monitoring services, CIS & EMRs will propel digital healthcare platform adoption'

5 mins

'Lack of sufficient capacity is a greatest challenge facing the biomanufacturing industry today'

Univercells Technologies, incorporated in Belgium in 2020 with the support of the Univercells group, is a global provider of innovative biomanufacturing technologies to achieve cost-effective viral production from R&D to commercial scales.

'Lack of sufficient capacity is a greatest challenge facing the biomanufacturing industry today'

5 mins

Les alle historiene fra BioSpectrum Asia

BioSpectrum Asia Magazine Description:

UtgiverMM Activ Sci-Tech Communication

KategoriBusiness

SpråkEnglish

FrekvensMonthly

BioSpectrum Asia Magazine is a monthly magazine published by MM Activ Sci-Tech Communication in India. It is a leading biotechnology magazine in Asia, covering a wide range of topics related to the biotechnology industry, including:

* Biotechnology news and trends: BioSpectrum Asia covers the latest biotechnology news and trends from India and around the world.
* Biotechnology company profiles and interviews: The magazine profiles leading biotechnology companies in Asia and interviews their CEOs and other top executives.
* Biotechnology research and development: BioSpectrum Asia covers the latest biotechnology research and development from academic institutions and pharmaceutical companies.
* Biotechnology product reviews: The magazine reviews the latest biotechnology products and services.
* Biotechnology industry events: BioSpectrum Asia covers biotechnology industry events from around the world.

BioSpectrum Asia Magazine is a must-read for anyone who wants to stay informed about the latest advances in biotechnology and their potential to impact the world around us.

  • cancel anytimeKanseller når som helst [ Ingen binding ]
  • digital onlyKun digitalt
MAGZTER I PRESSEN:Se alt